Liver transplant survival: does Donor-Recipient gender matter?
NCT ID NCT07250919
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at over 1,100 liver transplant patients to see if having a donor of a different gender affects long-term survival. Researchers followed patients for up to 10 years after transplant. The goal is to understand whether gender mismatch is a risk factor, which could help improve donor-recipient matching in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If clear patterns emerge, this could help doctors better match donors and recipients to improve survival after liver transplant.
- What could go wrong
- This is an observational study, not a trial testing a new treatment. It can show links but cannot prove cause and effect. Results may not apply to all transplant centers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto
Toronto, Ontario, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells predict herpesvirus danger in transplant patients?
- Muscle quality on MRI may foretell liver transplant success
- Better crystal ball for liver crisis: new scores put to the test
- A machine that keeps donor livers alive outside the body — could it transform transplantation?
- Frailty test could predict who survives liver transplant waiting list
- Could a single infusion of 'Trainer' cells free liver transplant patients from lifelong drugs?